IL-6 triggers proinflammatory signaling through soluble IL-6 receptor binding and subsequent JAK/MAPK and NF-κB pathway activation, resulting in oxidative stress, endothelial dysfunction, and retinal inflammation (41–44). The gene discussed is IL6; the disease is endothelial dysfunction.